Serina Therapeutics Inc (SER)
USD 6.13
(27.98%)
USD 6.13
(27.98%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -7.8 Million | -2.07 Million | -2.25 Million | -7.81 Million | -10.16 Million | -7.99 Million |
| Net Income | -14.8 Million | -2.68 Million | -1.26 Million | -10.39 Million | -12.15 Million | -7.5 Million |
| Depreciation & Amortization | 131 Thousand | 61.27 Thousand | 33.36 Thousand | 1.25 Million | 951 Thousand | 535 Thousand |
| Deferred income taxes | - | 401.78 Thousand | -225.38 Thousand | - | - | - |
| Stock-based compensation | - | 7110.00 | 82.94 Thousand | - | - | - |
| Change in working capital | 625 Thousand | -11.93 Thousand | -754.79 Thousand | -260 Thousand | -410 Thousand | 211 Thousand |
| Other non-cash items | 7.11 Million | 148.25 Thousand | -122.21 Thousand | 3.74 Million | 3.41 Million | -793 Thousand |
| Investing Cash Flow | -10 Million | 980.93 Thousand | 823.32 Thousand | -20 Thousand | -361 Thousand | 1.32 Million |
| Investments in PPE | - | -9682.00 | -108.43 Thousand | -20 Thousand | -641 Thousand | -1.89 Million |
| Acquisitions | - | - | 466 Thousand | - | - | - |
| Investment purchases | - | - | -666 Thousand | - | - | - |
| Sales/Maturities of investments | - | 990.61 Thousand | 931.75 Thousand | - | 354 Thousand | 3.21 Million |
| Other Investing Activities | -10 Million | - | 200 Thousand | - | -74 Thousand | 5000.00 |
| Financing Cash Flow | 17.5 Million | 1.31 Million | 1.07 Million | 5.96 Million | 6.26 Million | 6 Million |
| Debt repayment | -17.5 Million | -3.69 Million | -12.9 Thousand | -5.96 Million | -1.76 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 4422.00 | 496 Thousand | - | 4.5 Million | 6 Million |
| Other Financing Activities | - | - | 1 Million | - | - | - |
| Accounts receivables | -607 Thousand | 1109.00 | 1 Million | -30 Thousand | -232 Thousand | -24 Thousand |
| Accounts payables | - | -2131.00 | -367.28 Thousand | 382 Thousand | 169 Thousand | 648 Thousand |
| Inventory | - | -164.41 Thousand | 218.35 Thousand | - | - | - |
| Other working capital | 1.23 Million | 153.5 Thousand | -1.6 Million | -612 Thousand | -347 Thousand | -413 Thousand |
| Cash at beginning of period | 645 Thousand | 314.84 Thousand | 665.05 Thousand | 2.35 Million | 6.7 Million | 7.37 Million |
| Cash at end of period | 345 Thousand | 532.22 Thousand | 314.84 Thousand | 527 Thousand | 2.35 Million | 6.7 Million |
| Capital Expenditure | - | -9682.00 | -108.43 Thousand | -20 Thousand | -641 Thousand | -1.89 Million |
| Effect of forex changes on cash | - | - | - | 51 Thousand | -99 Thousand | - |
| Net cash flow / Change in cash | -300 Thousand | 217.38 Thousand | -350.2 Thousand | -1.82 Million | -4.35 Million | -668 Thousand |
| Free Cash Flow | -7.8 Million | -2.08 Million | -2.35 Million | -7.83 Million | -10.8 Million | -9.88 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.2 Million | -9.43 Million | -14.8 Million | -3.45 Million | -5.4 Million | -2.66 Million |
| Depreciation & Amortization | 57 Thousand | 25 Thousand | 131 Thousand | 33 Thousand | 33 Thousand | 32 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 458 Thousand | 53 Thousand | - | - | - | 22.32 Thousand |
| Change in working capital | -4.78 Million | 698 Thousand | 625 Thousand | 468 Thousand | 258 Thousand | -331 Thousand |
| Other non-cash items | -8.37 Million | 67 Thousand | 7.11 Million | 1.13 Million | 3.54 Million | 1.51 Million |
| Investing Cash Flow | - | -14 Thousand | -10 Million | - | - | -315.34 Thousand |
| Investments in PPE | - | -14 Thousand | - | - | - | -315.34 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -10 Million | - | - | - |
| Financing Cash Flow | 5.36 Million | 2.72 Million | 17.5 Million | 2 Million | 2 Million | 2 Million |
| Debt repayment | -379 Thousand | -2.38 Million | -17.5 Million | -2 Million | -2 Million | -2 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4.98 Million | 4000.00 | - | - | - | - |
| Other Financing Activities | 4.98 Million | 337 Thousand | - | - | - | - |
| Accounts receivables | - | - | -607 Thousand | -165 Thousand | -236 Thousand | -203 Thousand |
| Accounts payables | -2.04 Million | 644 Thousand | - | - | - | -301 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -4.8 Million | 698 Thousand | 1.23 Million | 633 Thousand | -173 Thousand | 173 Thousand |
| Cash at beginning of period | 8.7 Million | 7.61 Million | 645 Thousand | 397 Thousand | 261 Thousand | 280 Thousand |
| Cash at end of period | 6.06 Million | 8.75 Million | 345 Thousand | 345 Thousand | 397 Thousand | 261 Thousand |
| Capital Expenditure | - | -14 Thousand | - | - | - | -315.34 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.64 Million | 1.13 Million | -300 Thousand | -52 Thousand | 136 Thousand | -19 Thousand |
| Free Cash Flow | -8 Million | -1.59 Million | -7.8 Million | -2.05 Million | -1.86 Million | -2.33 Million |
ZENSARTECH
INKP
NCNC
JCGI
RVMD
UMI